Peer Review History
Original SubmissionSeptember 25, 2019 |
---|
PONE-D-19-26952 Vulnerability to psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter observational study PLOS ONE Dear Dr. Iijima, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Although your manuscript is interesting, the two reviewers addressed several major and minor concerns about your manuscript. Please revise your manuscript carefully. We would appreciate receiving your revised manuscript by Nov 29 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Kenji Hashimoto, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Please include additional information regarding the questionnaire regarding potential factors of disease exacerbation used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed this questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: 'This work was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (Grant No. 26460969).' We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 'The authors received no specific funding for this work.' 5. Thank you for stating the following in the Competing Interests section: 'The authors have declared that no competing interests exist.' We note that one or more of the authors are employed by a commercial company: Kinshukai Infusion clinic 1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests 6. Thank you for including your ethics statement: The ethics committees of all participating institutions approved the study protocol. Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors conducted an interesting multicenter cross-sectional survey to evaluate the association between psychological factors and disease activity in 1078 patients with inflammatory bowel diseases (IBD). In this study, patients believed that psychological stress was the most common factor for a trigger of their disease exacerbation. The authors also explored the association between CES-D or insomnia and disease activity. In the exploratory analyses, the authors conducted subgroup analyses based on whether patients believe psychological stress is the most important factor for a trigger of their disease exacerbation. The research question is interesting, and the data shown in this manuscript should be helpful for both healthcare providers and IBD patients to discuss the importance of assessing patients’ psychological condition. However, the manuscript is not straightforward. The authors should simply focus on their main research question in the manuscript. To make the manuscript simple and more reasonable, I have several comments below. <major comments=""> 1. The word, “vulnerability to psychological stress” may be improper because the authors did not measure the vulnerability such as lack of stress coping. I assume that “vulnerability to psychological stress” means that patients believed that psychological stress triggered their disease exacerbation in this study. This concept may be better to have a different name such as patients’ belief. 2. Instead of psychological stress, the authors measure depression (CES-D) and insomnia. The concept of psychological stress is different from depression and insomnia. The authors should clearly use the word such as depression and insomnia instead of psychological stress when they discuss depression and insomnia. In other words, the author should only use the word “psychological stress” when they discuss the results of questionnaire regarding factors related to disease exacerbation. 3. I believe that the most important information of this article may be that psychological stress was the most common factor for a trigger of their disease exacerbation. The authors should write the exact sentences to shown how they asked this question and what the choices were. 4. The authors used the word group 1 and group 2 which were based on whether patients answered whether psychological stress triggered their disease exacerbation. The expression of group 1 or group 2 may not be easy to follow for readers because name of group numbers (group 1 and group 2) are confusing. Please rename group1 and group 2 for readers’ understanding. 5. It seems that authors tried to show there is effect modification (i.e. interaction) between group 1 and group 2 regarding the association between CES-D or insomnia and disease activity. In the current analysis, the authors conducted only subgroup analyses based on group 1 and group2. Please show the p-value for interaction. Based on the p-value for interaction, the authors can discuss whether depression or insomnia are associated with disease activity in Group1 but not in Group 2. 6. The authors used CES-D as a continuous variable and showed the significant difference between remission and active patients in Group 1 in Figure 2. It may be better to use categorical variable such as depressive or not based on the cut-off written in the method section. If the authors use CES-D as a continuous variable, please discuss minimal clinically important difference (MCID) of CES-D. 7. Instead of table 1 and table 2, it may be better to show only patient characteristics in all patients, Group 1, and Group 2 in the same table without any statistical testing. In other words, the authors may delete table 1 and table 2, and they create a new table showing the patient characteristics. 8. I believe that the supplementary figure 1 is important because it shows patients’ selection. Please transfer the supplementary figure 1 to figure 1 in the manuscript. 9. There may be too many figures and supplementary figures. Please decrease the number of figures only focus on exacerbation factors and the subgroup analysis of Group 1/2 regarding depression and insomnia because this may be a main research question of this study. If this is not, the authors should show what is their main research question. 10. As shown in the supplementary figure 1, the authors selected the study population in two ways. If the authors decrease the number of figures and analyses, it may be possible to select patients in one process. 11. In the overall analyses, the authors showed only p-values in figures. Please show the point estimates such as mean difference and 95% intervals. This is important to discuss whether the difference is clinically important or not. This issue is related to MCID as I commented in No 6. 12. The authors should carefully interpret results in this study. Because this is the cross-sectional study, it is reasonable to consider the depression or insomnia is due to disease activity rather than vice-versa. Please discuss the results from the viewpoint above. Moreover, the authors should explain how patients’ belief (psychological stress triggered their disease exacerbation) affects the association of depression or insomnia with disease activity. In other word, please explain the mechanism of this effect modification if the authors find the significant interaction (please see the comments No 5). 13. Overall, there may be better words and sentences to show what the authors want to discuss in this manuscript. Please ask English editing to native and academic English editors. <minor comments=""> 1. It is better to show the study design in detail in the title. This is a multicenter cross-sectional survey or multicenter cross-sectional study. 2. In the introduction, the authors do not need to discuss seasonality because this is different from the current study purpose. 3. In the method section, please briefly mention the validity and reliability of CES-D and insomnia questionnaire based on previous questionnaire development study conducted by the developers. 4. In the introduction and discussion, the author should summarize previous studies evaluating patients’ belief of disease exacerbation triggers and discuss the discrepancy between the results of current study and those of previous studies with possible reasons. 5. In the introduction and discussion, the author should summarize previous studies evaluating depression or insomnia and disease activity, and please discuss the discrepancy between the results of current study and those of previous studies with possible reasons. Reviewer #2: This cross sectional study assessed psychological stress and insomnia in approximately 1,000 IBD subjects. The main findings were that most patients believed that stress is associated with disease activity and, in patients who believe this, that insomnia was also associated with disease activity. The data are well presented and my main concern is with the discussion surrounding the data. It has been known for many years that most patients believe that disease activity not only results stress, anxiety and depression, but that the converse is also true (that stress, anxiety and depression results in subsequent disease activity) and the findings from this paper are not novel in any way. The authors mention in the discussion that they are performing a prospective study and this would be a much more interesting study, allowing them to determine causative associations rather than just associations. Indeed, Gracie et al. (Gastroenterology 2018) have already shown that there is a bi-directional association between psychological disability and disease activity. With regard to insomnia, it is well known that sleep disturbance is intimately associated with psychological disability while it is also known that sleep disturbance is particularly common in those with gastrointestinal disorders. Indeed it would be surprising if disordered sleep patterns were not associated with active disease, merely by the effect of abdominal pain and diarrhoea on sleep. This does not mean that the study is of no value, but the discussion section should be altered to more accurately reflect the cross-sectional nature of the data. As an example, the statement " .. and the results suggest that psychological stress can be an initiator of disease" (line 281) is simply not appropriate. Similarly, the statement "our present data also suggest that high vulnerability to psychologic stress is associated with disease flare in patients with insomnia" (line 273) is not supported by the data. Finally, their conclusion "In conclusion, our data revealed that psychologic stress and insomnia affect disease activity in IBD patients, especially..." (line 292) is wrong, since it is just as likely that disease activity affects psychological stress and insomnia. The English, references and figures are appropriate </minor></major> ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-19-26952R1 Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study PLOS ONE Dear Dr. Iijima, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Again the reviewer addressed several major concerns about your revised manuscript. Please revise your manuscript carefully. We would appreciate receiving your revised manuscript by May 29 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Kenji Hashimoto, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This revision substantially improved the quality of reporting. However, there are several issues which the authors should clarify. Especially, the authors should explain why they believe that there is effect modification between PSTE groups (i.e. biological mechanism). 1. Please report the method to estimate P values for interactions in the Method section. 2. Please explain the possible biological mechanism which causes effect modification (i.e. interaction). 3. The authors answered that there is no defined MCID for CES-D. Please mention the search method for this (i.e. database for searching and search terms). I briefly searched and found one article related to MCID (PMID: 27300327). There should be more articles related to this issue. 4. In the results section of the abstract, please report the details of the results such as proportion, point estimate, and 95% CI. 5. Figure 1 is difficult to follow. Moreover, the numbers written in the Patients section seem different from those in Figure 1. Please check them. If the numbers are correct, please clearly report the study flow. The authors should also report how many patients visited the study sites during the study period and how many were actually recruited. 6. In the statistical analysis section, the description is too simple. Please report the details such as how they selected covariates for the logistic regression model. If the authors want to conduct causal inference, they need to select covariates based on theories instead of statistical covariate selection. 7. In figure 3, the authors compared between remission and active patients with stratification of PSTE. To harmonize the way of showing results to figure 3, figure 4 should also show the comparison between remission and active patients with stratification of PSTE without subgrouping CD/UC. 8. The authors should rethink the reasons to conduct multivariable analyses. They excluded “problems with work or family” from covariates because they thought that this was a potential confounder. If this is a confounder, it is better to adjust it to evaluate the independent association. However, the authors excluded it. Please explain for what purpose they conducted multivariable analyses. 9. In Table 2 and Table 3, it is difficult to understand the results. Please use same method to conduct univariate and multivariable analyses such as logistic regression models. Moreover, the method of covariate selection and purpose of these analyses are unclear. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study PONE-D-19-26952R2 Dear Dr. Iijima, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Kenji Hashimoto, PhD Section Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-19-26952R2 Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study Dear Dr. Iijima: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Kenji Hashimoto Section Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .